دورية أكاديمية

A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects.

التفاصيل البيبلوغرافية
العنوان: A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects.
المؤلفون: Cheng, Yiming, Ye, Ying, Gaudy, Allison, Ghosh, Atalanta, Xue, Yongjun, Wang, Alice, Zhou, Simon, Li, Yan
المصدر: Clinical Pharmacology; Feb2023, Vol. 15, p9-19, 11p
قاعدة البيانات: Complementary Index
الوصف
تدمد:11791438
DOI:10.2147/CPAA.S397826